67 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Company Limited
1 Jul 24
Current report (foreign)
6:33am
through reimbursement and patient assistance programs (PAPs). Additionally, ensuring transparency through disclosures of clinical trial results and quality … through reimbursement ALUNBRIG 9 TAKHZYRO 9 ALOFISEL 4 EXTIVITY 2 LIVTENCITY 2 TAKHZYRO 9 ALOFISEL 4 LIVTENCITY 6 Access to Medicines Programs in Low
424B2
TAK
Takeda Pharmaceutical Company Limited
28 Jun 24
Prospectus for primary offering
8:25am
and development of pharmaceutical products;
Government regulations over product development, regulatory approvals and reimbursement requirements
424B5
TAK
Takeda Pharmaceutical Company Limited
27 Jun 24
Prospectus supplement for primary offering
6:01am
and reimbursement requirements;
Laws and regulations governing the sales and marketing of our products;
Government policies and other pressures
F-3ASR
TAK
Takeda Pharmaceutical Company Limited
26 Jun 24
Automatic shelf registration (foreign)
8:26am
for the management of the affairs of such company entrusted to him or her, he or she may demand reimbursement therefor and interest thereon after
F-3ASR
EX-1.1
TAK
Takeda Pharmaceutical Company Limited
26 Jun 24
Automatic shelf registration (foreign)
8:26am
with the expense reimbursement payable by the Company pursuant to this Agreement.
SECTION 3. Covenants of the Company.
The Company covenants … and the Representatives, the Company agrees to pay or cause to be paid all reasonable costs and expenses (including reimbursement to the Underwriters) incident
6-K
EX-99.1
cnv y7yvg
29 May 24
Current report (foreign)
6:29am
6-K
EX-99.1
dzu26yzvdn8g toy7rd4
29 May 24
Current report (foreign)
6:29am
6-K
EX-99.1
xq34o7uoobp9t
6 Jul 23
Current report (foreign)
6:18am
S-8
kwaeyqy7g pjw
28 Jun 23
Registration of securities for employees
6:35am
6-K
EX-99.1
tsm3dkvdf1 dmv3rnzm
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
zrcbb5716nr2
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
4l9dr
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
o65tfh7 9zr
30 May 23
Current report (foreign)
6:11am
6-K
gf5b fs7ag
11 May 23
Current report (foreign)
6:07am
S-8
r8tu1pjiprkfh4a
29 Jun 22
Registration of securities for employees
6:13am